v3.22.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Federal grants $ 207,471 $ 444,516 $ 810,569 $ 695,091
Operating expenses:        
Research and development 5,311,298 463,219 8,451,394 787,595
General and administrative 1,951,356 393,914 4,217,161 884,386
Total operating expenses 7,262,654 857,133 12,668,555 1,671,981
Loss from operations (7,055,183) (412,617) (11,857,986) (976,890)
Other income (expense):        
Change in fair value of derivative liabilities 712,899 673,314
Change in fair value of convertible notes (88,763) 2,678,415
Change in fair value of liability classified warrants 148,393 2,942,791
Loss on debt conversions (892,636) (2,595,278)
Interest expense (37,781) (910,327) (52,802) (1,258,161)
Other income and expense, net 2,850 (347,566) 10,816 (347,566)
Total other income (expense), net (867,937) (544,994) 2,983,942 (932,413)
Net loss (7,923,120) (957,611) (8,874,044) (1,909,303)
Net loss attributable to noncontrolling interests (26,309) (22,067) (26,127) (26,028)
Deemed dividend related to warrants down round provision 102,479 818,059
Net loss attributable to common stockholders $ (7,999,290) $ (935,544) $ (9,665,976) $ (1,883,275)
Net loss per share:        
Net loss per share attributable to common stockholders, basic and diluted $ (0.24) $ (0.06) $ (0.32) $ (0.12)
Weighted average common shares outstanding, basic and diluted 33,988,783 16,053,550 30,656,712 15,943,867

Source